Article Details

Novel Tafasitamab Combination Finds a Role in Second-line DLBCL Treatment

Retrieved on: 2021-06-22 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Novel Tafasitamab Combination Finds a Role in Second-line DLBCL Treatment. View article details on hiswai:

Excerpt

With rituximab or other monoclonal antibodies, the mechanism of action is binding the antibody to CD19-positive B cells, which causes direct cell death ...

Article found on: www.targetedonc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up